Wandering Behavior: Clinical Trials

1 completed. 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	1	Completed 1

Follow Wandering Behavior: new trials by email Literature Review of Wandering Behavior trials Research Report on Wandering Behavior

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Fasudil fOr redUcing elopemeNt and Spatial Disorientation Oral Fasudil 90 mg/day, Oral Fasudil 180 mg/day, Oral Placebo - Dementia	Phase 2	Completed	Woolsey Pharmaceuticals	24	2020-12-15	2022-07-11

Narrower conditions

Dementia (1)

Broader conditions

Aberrant Motor Behavior in Dementia (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)

Interventions

fasudil (1)

Sponsors

Woolsey Pharmaceuticals (1)

Countries

Australia (1)  ·  United States (1)